Remember pandemic provision: How German innovations can help

Remember pandemic provision: How German innovations can help

provision for the future: teachings from corona pandemic

Corona pandemic has put many aspects of social life and economy to the test. The impressive speed with which vaccines were developed over a year was particularly striking. Usually the development of a drug needs up to a decade. This rapid reaction not only shows the innovative strength of science, but also illustrates the weaknesses in preparation for possible future pandemics.

A central point is the question of financial incentives in drug development. Diseases that promise potentially high profits - such as cancer or diabetes type 2 - attract the interest of the pharmaceutical companies. In contrast, the development of medication that could prevent viral outbreaks is under an unfavorable star, since the economic benefit remains unsafe. The Federal Employment Agency, Sprind, has presented an interesting concept: it wants to guarantee a decrease for medication that is developed to combat pandemics. This measure could get a socially valuable product an economic incentive.

This idea shows that long -term thinking in economic policy is urgently necessary. Politicians are often attempted to find only short -term solutions that are part of their election period. But in order to deal with future health crises safely, innovative approaches and strategic planning must come first.

The international competitiveness of Germany in business, especially in the area of ​​drug development, could be strengthened by these strategic planning. Although the market is often dominated by Anglo -Saxon institutions, Germany could use clever initiatives the opportunity to remain visible in this global field.

In order to really make progress, another important aspect must be taken into account: cooperation between countries. Pandemies do not respect any limits and require a coordinated international answer. Only if states pull together together can it be ensured that the development and spread of new medication remains economically attractive. National health can ultimately also secure care for global health.